[62Cu]DOTA-NOC

N/A

Report date: 2022/01/25 17:39:54

Base Information

Drug Name[62Cu]DOTA-NOC
Drug Alias Name62Cu-DOTA-NOC[62Cu]DOTANOC[62Cu]DOTA-NOC
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor modulators
TargetsSomatostatin receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIndiana University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIndiana University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A